METTL14/YTHDF2 m6A Axis Protects Against M2 Macrophage Polarization in Endometriosis by Regulating KLF4 Stability

Li Li1, Xiaoyan Wang2, You Wu2

  • 1Departnent of Reproductive Medicine, Affiliated Hospital of Zunyi Medical University, No. 149 Dalian Road, Zunyi, Guizhou Province, 563000, China. yi111_157@163.com.

Insights

The METTL14-m6A-KLF4 pathway influences macrophage polarization in endometriosis (EMs). This study reveals METTL14

Area of Science:

  • Reproductive Biology
  • Immunology
  • Molecular Biology

Background:

  • Endometriosis (EMs) is a chronic inflammatory condition linked to infertility and pain.
  • N6-methyladenosine (m6A) modification plays a role in EMs pathogenesis.
  • Understanding molecular mechanisms, like METTL14-m6A-KLF4 interactions, is crucial for EMs research.

Purpose of the Study:

  • To investigate the molecular mechanism of how METTL14-m6A-KLF4 regulates macrophage polarization in endometriosis.
  • To explore the impact of METTL14 and KLF4 on macrophage phenotypes (M1/M2) in the context of EMs.
  • To assess the effect of KLF4-activated M2 macrophages on endometrial stromal cell (ESC) progression.

Main Methods:

  • RT-qPCR to quantify METTL14 mRNA levels in tissues and cells.
  • Co-culture assays of macrophages with normal (nESCs) and ectopic (eESCs) endometrial stromal cells.
  • Assessment of M1/M2 macrophage markers (e.g., iNOS, IL-1β, Arg-1, IL-4, CD206, CD86) and KLF4 m6A modification.

Main Results:

  • METTL14 was underexpressed in EMs tissues and cells, correlating with M2 macrophage polarization.
  • Overexpression of METTL14 in eESCs co-cultured with macrophages downregulated M2 markers.
  • METTL14 mediated KLF4 m6A modification via YTHDF2, and KLF4 overexpression counteracted METTL14's effect on M2 polarization.
  • KLF4-activated M2 macrophages promoted ESC proliferation and migration in vitro.

Conclusions:

  • The METTL14-m6A-KLF4 axis is a key regulator of macrophage polarization in endometriosis.
  • Dysregulation of this pathway may contribute to EMs development and progression.
  • Targeting the METTL14-m6A-KLF4 pathway could offer therapeutic strategies for endometriosis.

Related Concept Videos